Table 1 Characteristic of the study participants.
From: Interleukin-31 expression and relation to disease severity in human asthma
Characteristic | Controls | Patients with asthma | p-value |
|---|---|---|---|
Number, n | 22 | 44 | |
Age, yrs | 38.6 ± 1.8 | 44.5 ± 2.3 | NS |
Sex (F/M) | 8/14 | 21/23 | NS |
BMI (kg/m2) | 22.3 ± 1.1 | 21.7 ± 1.5 | NS |
FEV1, % predicted | 93.4 ± 1.2 | 80.3 ± 3.1 | 0.004 |
≥80%, n (%) | 22 (100) | 22 (50) | |
60–79%, n (%) | 0 | 14 (31.8) | |
<60%, n (%) | 0 | 8 (19.2) | |
FEV1/FVC, % | 90.8 ± 3.4 | 77.1 ± 0.8 | < 0.001 |
Total IgE, kU/L | 138.2 ± 46.5 | 403.9 ± 51.8 | 0.002 |
Eosinophil in WBC% | 2.9 ± 0.4 | 5.1 ± 0.5 | 0.013 |
Atopy, n (%) | 0 | 23 (52.3) | |
House dust mites, n | – | 9 | |
Cockroaches, n | – | 5 | |
Cat, n | – | 3 | |
Dog, n | – | 3 | |
Ragweed, n | – | 2 | |
Alternaria, n | – | 1 | |
ACT score | NA | 20.7 ± 0.7 | |
25, n (%) | NA | 15 (34.1) | |
20–24, n (%) | NA | 18 (40.9) | |
5–19, n (%) | NA | 11 (25.0) |
